3 completed. 2 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow avenanthramide-2C: new trials by email Literature Review of avenanthramide-2C trials Research Report on avenanthramide-2C
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single and Multiple Ascending Oral Doses of Avenanthramide Avenanthramide, Placebo - Inflammation | Phase 1 / Phase 2 | Completed | Montreal Heart Institute | 92 | 2023-12-09 | 2026-04-20 |
| Avenanthramides and Exercise Avenanthramides - Avenanthramides | Not applicable | Completed | PepsiCo Global R&D | 24 | 2016-03-02 | 2021-03-10 |
| Bioavailability and Metabolism of Avenanthramide: a Novel Oat Phytochemical Avenanthramides - Bioavailability, Metabolism | Not applicable | Completed | PepsiCo Global R&D | 16 | 2015-01-05 | 2021-03-10 |
Inflammation (1)
PepsiCo Global R&D (2) · Montreal Heart Institute (1)
Canada (1)
Li Li Ji, PhD (2) · Jean-Claude Tardif, MD (1)